Bimolecular protease-based biosensor
US-2016223529-A1 · Aug 4, 2016 · US
US9791436B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9791436-B2 |
| Application number | US-201314427982-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 12, 2013 |
| Priority date | Sep 12, 2012 |
| Publication date | Oct 17, 2017 |
| Grant date | Oct 17, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A biosensor molecule comprises: a protease amino acid sequence; at least one sensor comprising at least one sensor amino acid sequence which is responsive to at least one target molecule; and an inhibitor of the protease activity of said protease amino acid sequence; wherein the biosensor is switchable from a protease active to a protease inactive state, or from a protease inactive to a protease active state when said sensor responds to said target molecule. The biosensor protease may be a protease of a virus such as a Potyvirus or a Flavivirus wherein the inhibitor is an autoinhibitory peptide derived from the virus. The biosensor may respond to the target molecule allosterically or may be cleaved by a target protease molecule.
Opening claim text (preview).
The invention claimed is: 1. A biosensor molecule comprising a protease amino acid sequence; at least one sensor comprising at least one sensor amino acid sequence which is responsive to at least one target molecule; and an inhibitor of the protease activity of said protease; wherein the biosensor is switchable from a protease active to a protease inactive state, or from a protease inactive to a protease active state when said sensor responds to said target molecule. 2. The biosensor of claim 1 , comprising (i) a single sensor comprising a single amino acid sequence responsive to a single target molecule; (ii) two sensors comprising respective amino acid sequences responsive to the same or different target molecule; (iii) a single protease amino acid sequence and a single inhibitor; and/or (iv) two different protease amino acid sequences and respective inhibitors. 3. The biosensor of claim 1 , wherein the or each sensor allosterically activates or inhibits the protease activity of the biosensor upon responding to the target molecule. 4. The biosensor of claim 3 , wherein the or each sensor allosterically releases inhibition of the or each protease by the inhibitor of the protease activity of said protease. 5. The biosensor of claim 1 , wherein the or each sensor comprises an affinity clamp; wherein the affinity clamp comprises a recognition domain; wherein the recognition domain is capable of binding one or more target molecules. 6. The biosensor of claim 5 , wherein the affinity clamp further comprises an enhancer domain. 7. The biosensor of claim 6 , wherein the recognition domain is a PDZ domain. 8. The biosensor of claim 6 , wherein the enhancer domain is a type III domain of fibronectin. 9. The biosensor of claim 1 , wherein the or each sensor comprises one or a plurality of epitopes that can be bound by an antibody target molecule, so that said sensor responds to said antibody target molecule. 10. The biosensor of claim 1 , wherein the or each sensor comprises an antibody which binds the target molecule. 11. The biosensor of claim 10 , which further comprises a molecule which binds the antibody. 12. The biosensor of claim 11 the molecule is a ZZ domain of Protein A which binds the antibody. 13. The biosensor of claim 1 , wherein the or each sensor amino acid sequence comprises a protease cleavage site cleavable by a protease target molecule to thereby at least partly release inhibition of the protease by the inhibitor and switch the biosensor from a protease active to a protease inactive state. 14. The biosensor of claim 1 , wherein the biosensor protease is a cysteine protease, a serine protease, an aspartate protease, a metalloprotease, a threonine protease, or a glutamic acid protease. 15. The biosensor of claim 14 , wherein the biosensor protease is derived or obtainable from a virus. 16. The biosensor of claim 15 , wherein the virus is a Potyvirus or a Flavivirus. 17. The biosensor of claim 16 , wherein the protease is an NIa protease. 18. The biosensor of claim 1 , wherein the inhibitor is a peptide. 19. The biosensor of claim 1 , which comprises first and second sensors responsive to the same or different target molecules. 20. The biosensor of claim 19 , which is a circularly permutated biosensor. 21. The biosensor of claim 1 further comprising an amplifier interacting domain for linking or coupling the biosensor to an amplifier molecule. 22. The biosensor of claim 1 comprising an amino acid sequence set forth in any one of SEQ ID NOS: 1-10. 23. An amplifier molecule operable with the biosensor molecule of claim 1 that comprises: (i) an amino acid sequence of a protease that is different to the protease(s) of the biosensor; (ii) an inhibitor of the protease of (i); and (iii) a linker amino acid sequence which comprises a cleavage site for the protease(s) of the biosensor. 24. The amplifier molecule of claim 23 which comprises a biosensor interacting domain for linking or coupling the amplifier molecule to the biosensor. 25. A composition or kit comprising the biosensor of claim 1 and a substrate. 26. The composition or kit of claim 25 , wherein the substrate comprises an amino acid sequence cleavable by the protease of the biosensor. 27. The composition or kit of claim 25 , further comprising an amplifier molecule. 28. The composition or kit of claim 25 , further comprising a deactivating molecule. 29. The composition or kit of claim 28 , further comprising an amplifier molecule operable with the biosensor, wherein the amplifier molecule comprises: (i) an amino acid sequence of a protease that is different to the protease(s) of the biosensor, (ii) an inhibitor of the protease of (i), and (iii) a linker amino acid sequence which comprises a cleavage site for the protease(s) of the biosensor; wherein the deactivating molecule comprises: (i) an amino acid sequence of a protease that is different to the protease(s) of the biosensor and that is different to the protease of the amplifier molecule; (ii) an inhibitor of the protease of (i) and (iii) a linker amino acid sequence which comprises a cleavage site for the protease of the amplifier molecule. 30. The composition or kit of claim 25 , further comprising an amplifier molecule operable with the biosensor, wherein the amplifier molecule comprises: (i) an amino acid sequence of a protease that is different to the protease(s) of the biosensor, (ii) an inhibitor of the protease of (i), and (iii) a linker amino acid sequence which comprises a cleavage site for the protease(s) of the biosensor; wherein the substrate comprises an amino acid sequence cleavable by the protease of the amplifier molecule. 31. The composition or kit of claim 25 , wherein the substrate comprises a label. 32. A method of detecting a target molecule, said method including the step of contacting the composition of claim 25 with a sample to thereby determine the presence or absence of a target molecule in the sample.
containing a His-tag · CPC title
Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody® · CPC title
Togaviridae; Flaviviridae · CPC title
against blood coagulation factors · CPC title
derived from RNA viruses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.